Stem Cell Treatment for Children with Autism

GetWellGo provides world-class stem cell therapy for autism in children. Comprehensive support and care for international patients seeking effective treatment.

Stem Cell Treatment for Children with Autism

Stem cell treatment for autism in children

The research on the stem cell treatment of autism in children is still developing, and it is not yet a standard of medical practice, although it is experimental. Here’s a detailed overview:

What stem cell therapy for autism entails?

Types of stem cells used:

  • Mesenchymal stem cells derived out of umbilical cord (MSCs).
  • Stem cells of the bone marrow.
  • Stem cells obtained in adipose (fat) tissue.
  • Infusion of blood of umbilical cord (occasionally in trials).

Proposed mechanism:

  • It is thought that stem cells help by decreasing neuroinflammation, enhancing the immune system, and potentially promoting the neural connectivity.
  • It aims at enhancing the functions of behavior, cognition, and communication among children with autism spectrum disorder (ASD).

Current Evidence

Small-scale (primarily in China, India, Panama, and the U.S.) clinical trials have varied results:

  • There were some children whose eye contact, social interaction, speech, and hyperactivity were improved.
  • Other trials showed little or no better outcome as compared to placebo.
  • The risks and benefits in the long term are unclear.

Key studies:

  • A 2017 Duke University trial infusing the infants with umbilical cord blood demonstrated slight gains in behavior in certain children, but not in all those that took part.
  • Follow-up trials are being done on larger populations to establish safety and efficacy.

Best stem cell therapy for autism

The following are the types, delivery, dosages that appear to be more effective or demonstrate more consistent benefit in published trials and meta-analysis:

  • Type of stem cells: Umbilical cord-derived mesenchymal stem cells (UC-MSCs) or cord blood/cord tissue stem cell, commonly allogeneic (donor). In certain studies, bone marrow mesenchymal stem cells (BM-MSCs) (autologous) are used. 
  • Routes of delivery: There was intrathecal injection (into the spine) of BM-MSCs in some trials, usually along with rehabilitation therapy and other standard therapeutic interventions such as risperidone. 
  • Other trials: intravenous infusion or combination delivery is to be used. The exact pathway is of importance to the extent to which cells can access the brain / affect neuroinflammation etc.
  • Child age / timing: Earlier intervention is more likely to provide more opportunity of observable improvement (when the brain is more plastic) but little-strong evidence has been found. There are reports of children in younger age responding better. 
  • Combination with other therapies: Stem cell therapy is nearly always researched together with behavioral, speech, occupational therapies etc. The stem cell component may assist in the underlying condition (e.g. immune system, inflammation) but it does not substitute the regular treatments of autism. 
  • Safety profile: Up to this point, the meta-analyses are not indicating serious adverse events in large numbers, but the incidences of mild to moderate adverse events (fever, headache etc) are present. Nevertheless, safety is not well-established in the long-term in particular with recurring treatments.

Stem cell therapy for autism success rate

The improvement rates reported are all over the place (about 40-90 percent in various studies and outcome measures), whereas these figures are based on small, heterogeneous trials using various cell types, doses, routes, ages, and measurement tools.

Factors Affecting Cost of stem cell treatment for autism

Type of Stem Cells Used

  • Umbilical Cord Blood / Cord Tissue Stem Cells- tend to be more costly to source, process and store.
  • Bone Marrow-Derived Stem Cells - can be less expensive when used (autologous) on the child, however, the harvesting procedure is expensive.
  • Adipose (Fat) -Derived Stem Cells - less frequently used, but is sometimes cheaper.

Source of Stem Cells

  • Autologous (of the own body of the child) - demands harvesting and processing.
  • Allogeneic (donor, usually umbilical cord) - entails screening, matching and advanced lab preparation.

Delivery Method

  • Intravenous (IV) Infusion - tends to be cheaper.
  • Intrathecal Injection (spinal canal) more complicated, which means that it has to be anesthetized and hospitalized, hence more expensive.
  • Combination routes - can be even more costly.

Number of Sessions Required

  • These protocols include one session, and some have more than one session (2-6+ sessions during weeks or months).
  • The more the sessions, the more the cost.

Location of Hospital 

Costs differ by geography:

  • India, China, Ukraine, Mexico - on average, cheaper.
  • U.S/Western Europe- far greater, predominantly in clinical trials.
  • Panama and Thailand - mid to high range international patients.

Hospital Reputation and Accreditation

  • Advanced lab hospitals/clinics usually accredited internationally tend to be more expensive than small private centers.
  • Additional charges may be charged in specialized pediatric neurology or stem cell institutes.

Doctor Expert and Involvement of Team

  • The presence of skilled experts in the field of regenerative medicine, pediatric neurology, and anaesthesiology drives up expenses.

Further Therapies and Rehabilitation

In combination with stem cell therapy, one can often find:

  • Behavioral therapy (ABA, occupational therapy, speech therapy).
  • Drugs (such as risperidone)
  • Such bundled programs have the potential of increasing costs.

Length of stay and services

  • Costs are added by hospital stay, follow-up care, numerous diagnostic tests (MRI, blood work), and supportive care.
  • International patient packages can contain translators, travel services and lodging- increasing overall cost.

Stem cell therapy for autism in India

The most frequently studied treatments against autism involve mesenchymal stromal/stem cells (of umbilical cord tissue or cord blood, bone marrow, or adipose tissue) administered intravenously or occasionally into the spinal column. The reason can be decreased neuroinflammation and control immune activity to enhance social, communication, or behavioral symptoms. 

What the evidence shows?

  • A number of systematic reviews and meta-analyses claim statistically significant change on certain measures of autism (e.g., CARS) following stem-cell treatments, although many studies differ greatly in the type of cell, dose, route and outcome measures. Evidence quality is limited. 
  • Individual randomized trials demonstrate mixed findings; some have modest improvements in subgroups (e.g. younger children or higher-cognitive baseline), others have small or no improvement in global measures. 
  • The safety in trials (in the short-term, most of them are mild-to-moderate, and transient adverse events) is usually satisfactory, whereas the long-term safety and sustainability of benefit are not well-established.

Autism stem cell treatment hospitals India

Stem cell treatment for children with autism GetWellGo

GetWellGo is regarded as a leading supplier of healthcare services. We help our foreign clients choose the best treatment locations that suit their needs both financially and medically.

We offer:

  • Complete transparency
  • Fair costs.
  • 24 hour availability.
  • Medical E-visas
  • Online consultation from recognized Indian experts.
  • Assistance in selecting India's top hospitals for Stem cell treatment for children with autism.
  • Expert doctor with a strong track record of success
  • Assistance during and after the course of treatment.
  • Language Support
  • Travel and Accommodation Services
  • Case manager assigned to every patient to provide seamless support in and out of the hospital like appointment booking
  • Local SIM Cards
  • Currency Exchange
  • Arranging Patient’s local food

 

Recent Blogs